Antibiotic Duration Domain Part A and Part B
October 1, 2024
The Antibiotic Duration domain (Parts A and B) outlines the details of the study, including what will happen if a participant chooses to join. It explains the different randomisation groups (arms) in both parts of the study, what each group will experience, and the reason for including these groups. It also covers potential risks associated with participating in this domain.